{"id":"https://openalex.org/W2009780965","doi":"https://doi.org/10.3109/03639045.2014.938655","title":"Solid self microemulsification of Atorvastatin using hydrophilic carriers: a design","display_name":"Solid self microemulsification of Atorvastatin using hydrophilic carriers: a design","publication_year":2014,"publication_date":"2014-07-14","ids":{"openalex":"https://openalex.org/W2009780965","doi":"https://doi.org/10.3109/03639045.2014.938655","mag":"2009780965","pmid":"https://pubmed.ncbi.nlm.nih.gov/25019500"},"language":"en","primary_location":{"id":"doi:10.3109/03639045.2014.938655","doi":"https://doi.org/10.3109/03639045.2014.938655","is_oa":false,"landing_page_url":"https://doi.org/10.3109/03639045.2014.938655","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034890218","display_name":"Raj Kishore","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Nanda Kishore","raw_affiliation_strings":["Pharmaceutics Division, Sree Vidyanikethan College of Pharmacy , A. Rangampet, Tirupati , India and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Division, Sree Vidyanikethan College of Pharmacy , A. Rangampet, Tirupati , India and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057042369","display_name":"Prasanna Raju Yalavarthi","orcid":"https://orcid.org/0000-0001-7859-0475","observed_orcids":["https://orcid.org/0000-0001-7859-0475"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Prasanna Raju Yalavarthi","raw_affiliation_strings":["Pharmaceutics Division, Sree Vidyanikethan College of Pharmacy, A. Rangampet, Tirupati, India and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Division, Sree Vidyanikethan College of Pharmacy, A. Rangampet, Tirupati, India and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047257519","display_name":"Harini Chowdary Vadlamudi","orcid":"https://orcid.org/0000-0003-0719-0903","observed_orcids":["https://orcid.org/0000-0003-0719-0903"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harini Chowdary Vadlamudi","raw_affiliation_strings":["Pharmaceutics Division, Sree Vidyanikethan College of Pharmacy, A. Rangampet, Tirupati, India and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Division, Sree Vidyanikethan College of Pharmacy, A. Rangampet, Tirupati, India and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042496361","display_name":"KR Vandana","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K. R. Vandana","raw_affiliation_strings":["Pharmaceutics Division, Sree Vidyanikethan College of Pharmacy, A. Rangampet, Tirupati, India and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Division, Sree Vidyanikethan College of Pharmacy, A. Rangampet, Tirupati, India and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054463978","display_name":"Arun Rasheed","orcid":"https://orcid.org/0000-0002-3870-9328","observed_orcids":["https://orcid.org/0000-0002-3870-9328"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arun Rasheed","raw_affiliation_strings":["Department of Medicinal Chemistry, Al-Shifa College of Pharmacy, Poonthavanam, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Al-Shifa College of Pharmacy, Poonthavanam, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113952264","display_name":"M Sushma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Sushma","raw_affiliation_strings":["Pharmaceutics Division, Sree Vidyanikethan College of Pharmacy, A. Rangampet, Tirupati, India and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutics Division, Sree Vidyanikethan College of Pharmacy, A. Rangampet, Tirupati, India and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5057042369"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4876,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.76925038,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"41","issue":"7","first_page":"1213","last_page":"1222"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10721","display_name":"Surfactants and Colloidal Systems","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1606","display_name":"Physical and Theoretical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-solubility-enhancement","display_name":"drug solubility enhancement","score":0.8159999847412109},{"id":"https://openalex.org/keywords/hydrophilic-carriers","display_name":"hydrophilic carriers","score":0.671999990940094},{"id":"https://openalex.org/keywords/pseudo-ternary-phase-diagram","display_name":"pseudo-ternary phase diagram","score":0.781000018119812},{"id":"https://openalex.org/keywords/drug-release","display_name":"drug release","score":0.5320000052452087},{"id":"https://openalex.org/keywords/shelf-life","display_name":"shelf life","score":0.7289999723434448},{"id":"https://openalex.org/keywords/dissolution-profile","display_name":"dissolution profile","score":0.4480000138282776},{"id":"https://openalex.org/keywords/lipid-phase","display_name":"lipid phase","score":0.4339999854564667}],"concepts":[{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.734790027141571},{"id":"https://openalex.org/C190119865","wikidata":"https://www.wikidata.org/wiki/Q338019","display_name":"Microemulsion","level":3,"score":0.714339554309845},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6480057239532471},{"id":"https://openalex.org/C187530423","wikidata":"https://www.wikidata.org/wiki/Q7140503","display_name":"Particle size","level":2,"score":0.6252164244651794},{"id":"https://openalex.org/C58226133","wikidata":"https://www.wikidata.org/wiki/Q1324199","display_name":"Pulmonary surfactant","level":2,"score":0.6236148476600647},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.5437480211257935},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.5238739848136902},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.5189704298973083},{"id":"https://openalex.org/C11432220","wikidata":"https://www.wikidata.org/wiki/Q1975334","display_name":"Dispersity","level":2,"score":0.5177411437034607},{"id":"https://openalex.org/C86181022","wikidata":"https://www.wikidata.org/wiki/Q196823","display_name":"Zeta potential","level":3,"score":0.5167074203491211},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.49373969435691833},{"id":"https://openalex.org/C2781011878","wikidata":"https://www.wikidata.org/wiki/Q7118931","display_name":"PEG 400","level":3,"score":0.4532722532749176},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.4429205060005188},{"id":"https://openalex.org/C199529486","wikidata":"https://www.wikidata.org/wiki/Q7557912","display_name":"Solid lipid nanoparticle","level":3,"score":0.43843743205070496},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.340160608291626},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.26761168241500854},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.2585442066192627},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.22520586848258972},{"id":"https://openalex.org/C2776964284","wikidata":"https://www.wikidata.org/wiki/Q410083","display_name":"Polyethylene glycol","level":2,"score":0.08351916074752808},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.07242920994758606},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.06831005215644836},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002626","descriptor_name":"Chemistry, Pharmaceutical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004337","descriptor_name":"Drug Carriers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004356","descriptor_name":"Drug Storage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004655","descriptor_name":"Emulsions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010316","descriptor_name":"Particle Size","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013501","descriptor_name":"Surface-Active Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014783","descriptor_name":"Viscosity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D057927","descriptor_name":"Hydrophobic and Hydrophilic Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065546","descriptor_name":"Drug Liberation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3109/03639045.2014.938655","doi":"https://doi.org/10.3109/03639045.2014.938655","is_oa":false,"landing_page_url":"https://doi.org/10.3109/03639045.2014.938655","pdf_url":null,"source":{"id":"https://openalex.org/S162444473","display_name":"Drug Development and Industrial Pharmacy","issn_l":"0363-9045","issn":["0363-9045","1520-5762"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development and Industrial Pharmacy","raw_type":"journal-article"},{"id":"pmid:25019500","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25019500","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development and industrial pharmacy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W53556269","https://openalex.org/W1510298788","https://openalex.org/W1682768769","https://openalex.org/W1997178814","https://openalex.org/W1998095036","https://openalex.org/W2015649805","https://openalex.org/W2038365601","https://openalex.org/W2041016731","https://openalex.org/W2041622541","https://openalex.org/W2042403886","https://openalex.org/W2054202295","https://openalex.org/W2063209823","https://openalex.org/W2069983835","https://openalex.org/W2078111431","https://openalex.org/W2082491791","https://openalex.org/W2088422411","https://openalex.org/W2098293253","https://openalex.org/W2107841008","https://openalex.org/W2135863657","https://openalex.org/W2137572701","https://openalex.org/W2157187673","https://openalex.org/W2331653374","https://openalex.org/W2332526825","https://openalex.org/W4254368641"],"related_works":["https://openalex.org/W7168287501","https://openalex.org/W7217828735","https://openalex.org/W1580302133","https://openalex.org/W2526829828","https://openalex.org/W836951197","https://openalex.org/W2969704930","https://openalex.org/W3135689082","https://openalex.org/W2101308945","https://openalex.org/W2397302576","https://openalex.org/W2059740626"],"abstract_inverted_index":{"CONTEXT:":[0],"Atorvastatin":[1,17],"has":[2],"a":[3,139,151,159],"limited":[4],"advantage":[5],"to":[6,19,76,150,179,194],"formulate":[7],"oral":[8],"dosage":[9],"forms.":[10],"OBJECTIVE:":[11],"To":[12],"enhance":[13],"the":[14,21,78,164,214],"solubility":[15],"of":[16,134,161,166,213,228],"and":[18,30,34,46,58,66,95,106,124,169,240],"design":[20],"suitable":[22],"solid":[23,99,117,146,200,211,226],"self-microemulsifying":[24,36],"drug":[25,37,96,122,143,191,215],"delivery":[26,38],"systems":[27],"(S-SMEDDS)":[28],"Materials":[29],"methods:":[31],"The":[32,69,81,98,110,127,145,184,199,210,225],"clear":[33],"transparent":[35],"system":[39],"(SMEDDS)":[40],"were":[41,74,83,101,112],"formulated":[42,234],"using":[43],"coconut":[44],"oil":[45],"isopropyl":[47],"myristate":[48],"as":[49,54,60,171],"lipid":[50],"phases;":[51],"Tween":[52],"80":[53],"surfactant;":[55],"PEG":[56],"400":[57],"glycerin":[59],"co-surfactant":[61],"at":[62,163],"2:1,":[63],"3:1,":[64],"1:2":[65],"1:3":[67,185],"ratio.":[68],"pseudo":[70],"ternary":[71],"phase":[72],"diagrams":[73],"constructed":[75],"identify":[77],"microemulsion":[79,153],"region.":[80],"SMEDDS":[82,100,147,187,201,231],"evaluated":[84,113],"for":[85,114],"zeta":[86],"potential,":[87],"poly":[88],"dispersity":[89],"index,":[90],"globule":[91],"size,":[92],"pH,":[93],"viscosity":[94],"release.":[97,144],"developed":[102],"by":[103],"employing":[104],"adsorption":[105],"melt":[107],"granulation":[108],"methods.":[109],"S-SMEDDS":[111],"micromeritics,":[115],"morphology,":[116],"state":[118,212],"property,":[119],"reconstitution":[120],"ability,":[121],"release":[123,160,192],"stability.":[125],"RESULTS:":[126],"micro":[128],"formulations":[129],"formed":[130],"with":[131,158,236],"particle":[132,197],"size":[133],"25":[135],"nm":[136],"had":[137,148,188,202,216,232],"shown":[138,189,203],"3-folds":[140],"rise":[141],"in":[142,155,218],"reconstituted":[149],"good":[152],"rapidly":[154],"1-3":[156],"min,":[157],"94.62%":[162],"end":[165],"30":[167],"min":[168],"behaved":[170],"immediate":[172],"releasing":[173],"capsules.":[174],"Their":[175],"shelf-life":[176],"was":[177],"found":[178],"be":[180],"1.3":[181],"years.":[182],"DISCUSSION:":[183],"ratio":[186],"more":[190],"owing":[193],"their":[195,221],"less":[196],"size.":[198],"an":[204],"increased":[205],"dissolution":[206],"profiles":[207],"than":[208],"atorvastatin.":[209],"changed":[217],"formulation":[219],"inferring":[220],"enhanced":[222,237],"solubility.":[223,241],"CONCLUSION:":[224],"form":[227],"atorvastatin":[229],"liquid":[230],"been":[233],"successfully":[235],"shelf":[238],"life":[239]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}